Insider · CIK 0001405692
Cynthia Collins
director
Files at CDXS (CODEXIS, INC.), MXCT (MAXCYTE, INC.), PSTX (Poseida Therapeutics, Inc.), CERT (Certara, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2025 | MXCT MAXCYTE, INC. | AGrant or award Common Stock | +29,210 | $0.00 | $0 | 80,889 | Jun 23, 2025 |
| Jun 18, 2025 | MXCT MAXCYTE, INC. | AGrant or award Stock Option (right to buy)derivative | +50,790 | $0.00 | $0 | 50,790 | Jun 23, 2025 |
| Jun 10, 2025 | CDXS CODEXIS, INC. | AGrant or award Common Stock | +40,983 | $0.00 | $0 | 112,157 | Jun 12, 2025 |
| May 21, 2025 | CERT Certara, Inc. | MOption exercise Common Stock | +11,928 | $0.00 | $0 | 36,089 | May 22, 2025 |
| May 21, 2025 | CERT Certara, Inc. | MOption exercise Restricted Stock Unitsderivative | -11,928 | $0.00 | $0 | 0 | May 22, 2025 |
| May 21, 2025 | CERT Certara, Inc. | AGrant or award Restricted Stock Unitsderivative | +15,757 | $0.00 | $0 | 15,757 | May 22, 2025 |
| Mar 28, 2025 | CDXS CODEXIS, INC. | AGrant or award Common Stock | +71,174 | $0.00 | $0 | 71,174 | Apr 1, 2025 |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | UTender of shares Common Stock | -58,950 | - | - | 0 | Jan 8, 2025 |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -87,440 | $0.00 | $0 | 0 | Jan 8, 2025 |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -28,500 | $0.00 | $0 | 0 | Jan 8, 2025 |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -27,350 | $0.00 | $0 | 0 | Jan 8, 2025 |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -27,350 | $0.00 | $0 | 0 | Jan 8, 2025 |
| Oct 14, 2024 | MXCT MAXCYTE, INC. | AGrant or award Common Stock | +51,679 | $0.00 | $0 | 51,679 | Oct 16, 2024 |
| Oct 14, 2024 | MXCT MAXCYTE, INC. | AGrant or award Stock Option (right to buy)derivative | +97,698 | $0.00 | $0 | 97,698 | Oct 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.